| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 450 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 450 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 146 | 134 | 130 | 128 | 125 | 123 | 151 | 0 | 0 | 102 |
| Gross Profit/Loss - EUR | 303 | -134 | -130 | -128 | -125 | -123 | -151 | 0 | 0 | -102 |
| Net Profit/Loss - EUR | 290 | -134 | -130 | -128 | -125 | -123 | -151 | 0 | 0 | -102 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Doctorvulpe Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 495 | 490 | 482 | 473 | 464 | 455 | 445 | 892 | 0 | 885 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 446 | 0 | 442 |
| Receivables | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 0 | 402 |
| Cash | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Shareholders Funds | 99 | -90 | -219 | -343 | -461 | -576 | -713 | 41 | 0 | -62 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | 396 | 580 | 700 | 815 | 925 | 1.030 | 1.158 | 852 | 0 | 947 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Doctorvulpe Srl